Tag Archives: Data

With Gamifant launch rolling, Sobi unveils more data backing the rare disease med

SAN DIEGO—Armed with last month’s FDA approval, Sobi is rolling out its newly minted rare disease drug Gamifant with a small, targeted sales force, and Monday it unveiled more of the data that won the agency’s favor in the first place. In a phase 2/3 trial of Gamifant in primary haemophagocytic lymphohistiocytosis (HLH), 64.7% of… Read More »

ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah

SAN DIEGO—Gilead and Novartis are working to ramp up launches of their slow-starting CAR-T drugs, and both companies are hoping longer-term follow-up data will help do the trick. Sunday at the American Society of Hematology (ASH) annual meeting, Gilead’s Kite unit rolled out two-year data from the Zuma-1 study that won Yescarta its October 2017 approval… Read More »

More than half of health data breaches triggered internally, study finds

Dive Brief: Breaches of protected health information can seriously harm an organization’s brand and finances, but little is known about how breaches occur and the steps organizations take to prevent a recurrence, according to a research letter in JAMA Internal Medicine. The researchers analyzed 1,138 breach cases that occurred between Oct. 21, 2009, and Dec. 31,… Read More »